Homeβ€ΊSearchβ€ΊGerman Journal of Pharmaceuticals and Biomaterials

German Journal of Pharmaceuticals and Biomaterials

German Journal of Pharmaceuticals and Biomaterials Β· Germany Β· Est. 2022

ISSN2750-624XeISSN2750-6258
βœ“ DOAJβœ“ Open Access
15
/ 100
High Risk
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
βœ“ DOAJ Verified+15
Total15
H-Indexi
5
Total Worksi
69
Total Citationsi
120
2yr Mean Citednessi
0.63
Open Impact Factor alternative

Aims & Scope

German Journal of Pharmaceuticals and Biomaterials (GJPB) is an interdisciplinary peer-reviewed open access scientific journal that publishes high-quality experimental and theoretical research that contributes significantly to all aspects of pharmaceutical sciences and biomaterials and their related subjects including their applications in human (covering experimental and clinical therapeutics). The mission is to publish scientific work that has followed laborious methodologies and contribute to progress and development in pharmaceuticals and biomaterials. Scientific areas within the scope of this journal include but are not limited to pharmaceutics (all aspects of formulations and drug delivery systems, including oral, pulmonary, nasal, parenteral and transdermal delivery) and biopharmaceutics, including pharmaceutical biotechnology products, biochemistry and microbiology, pharmacology and toxicology, applied separation science (covers all areas of analytical/chromatography techniques), natural product drug discovery, medicinal chemistry, and bioactive polymers. This journal is also interested in work that addresses biomaterials but is not limited to covering all aspects of biomaterials with a broad range of physical, biological and chemical sciences that support the design of biomaterials and the clinical/scientific disciplines in which they are used.

General Information

Country / RegionGermany
Primary LanguageEnglish
1st Year Published2022
FrequencyQuarterly
StatusActive (last: 2025)
Total Publications69
Publisher OrgEManuscript Services
OA Since2021
Visit Journal Website

Submission Info

Peer ReviewDouble anonymous peer review
Review Timeβ€”
Acceptance Rateβ€”
OA LicenseCC BY
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes

Think.Check.Submit Compliance

9/12 Β· 75%
βœ…
Do you know the journal / publisher?
German Journal of Pharmaceuticals and Biomaterials
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
2750-624X / 2750-6258
βœ…
Indexed in a trusted database?
DOAJ
βœ…
Peer review process documented?
Double anonymous peer review
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
17
69
2022
17
35
2023
17
22
2024
18
0
2025

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

Subject Classification

Research Topics (OpenAlex)

Drug Solubulity and Delivery SystemsPolysaccharides Composition and ApplicationsComputational Drug Discovery Methodsbiodegradable polymer synthesis and propertiesAdvancements in Transdermal Drug DeliveryAdvanced Drug Delivery SystemsNatural Antidiabetic Agents StudiesFood composition and propertiesSynthesis and biological activityRNA Interference and Gene Delivery

Frequently asked questions about German Journal of Pharmaceuticals and Biomaterials

Is German Journal of Pharmaceuticals and Biomaterials a predatory journal?

No major predatory indicators were found for German Journal of Pharmaceuticals and Biomaterials. It is indexed in DOAJ and has a PubScope Trust Score of 15/100. Always confirm fit and policies before submitting.

What is the impact factor of German Journal of Pharmaceuticals and Biomaterials?

German Journal of Pharmaceuticals and Biomaterials is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its open 2-year mean citedness is 0.63.

Is German Journal of Pharmaceuticals and Biomaterials indexed in Scopus and Web of Science?

German Journal of Pharmaceuticals and Biomaterials is indexed in DOAJ.

What is the aims and scope of German Journal of Pharmaceuticals and Biomaterials?

German Journal of Pharmaceuticals and Biomaterials (GJPB) is an interdisciplinary peer-reviewed open access scientific journal that publishes high-quality experimental and theoretical research that contributes significantly to all aspects of pharmaceutical sciences and biomaterials and their related subjects including their applications in human (covering experimental and clinical therapeutics). The mission is to publish scientific work that has followed laborious methodologies and contribute to progress and development in pharmaceuticals and biomaterials. Scientific areas within the scope of

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-26 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref